Ziad Makhzoumi

Ziad Makhzoumi is a globally recognized executive and strategic advisor with over four decades of experience leading transformations, M&A transactions, and growth strategies across healthcare, infrastructure, and private equity. 

Ziad began his career at Booz Allen Hamilton in 1981, where he played a pivotal role in strategic consultancy and private equity buyouts across Europe, the Middle East, and North America. From 2008 to 2012, he served as Chief Financial Officer of Arabtec Holding PJSC, one of the region’s largest publicly traded construction firms. Under his leadership, Arabtec became the most actively traded stock on the Dubai Financial Market—navigating the 2008 global crisis with resilience and financial stability.

In 2013, Ziad transitioned into healthcare as CEO of Fakih IVF Group, where he led the expansion of a single clinic into the UAE’s market leader in fertility services. In 2015, he successfully negotiated the $500M sale of Fakih IVF to NMC Health, one of the region’s largest healthcare transactions at the time.

Ziad’s contributions have earned him international recognition, including:

-Top 20 Influential Non-Royal Decision Makers in the UAE (Wall Street Journal, 2010)
-Top 500 Most Influential Arabs in the     World (Arabian Business, 2012)
-Top 50 Influential Brits in the UAE (Arabian Business, 2013 & 2014)
-Middle East CEO of the Year – Healthcare (CEO Middle East Magazine, 2014)

Today, Ziad brings his global expertise in deal execution, operational excellence, and healthcare leadership to support the JL Capital Group and the American Health at Home Fund mission to build the largest privately owned home healthcare platform in the U.S.